Bastyr University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Bastyr University sits in the top decile of US sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count).

19 total trials 2 currently recruiting 15 completed early-phase tilt top decile by trial count

Bastyr University: 19 sponsored US clinical trials, 2 recruiting.

Bastyr University sponsors 19 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 15 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinson's Disease, with 2 trials.

Top-decile sponsor footprint

Bastyr University ranks in the top decile of sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

15 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

19 total, page 1 of 1

RECRUITING

Modifiable Variables in Parkinsonism (MVP)

NCT02194816

RECRUITING

Complementary and Alternative Care in Multiple Sclerosis

NCT01703429

COMPLETED NA

Biofeedback for Psoriasis

NCT05506644

COMPLETED NA

Omega 7 Oil and Inflammatory Biomarker Study

NCT03669575

COMPLETED Phase 2

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease

NCT02424708

COMPLETED

Cannabis and Parkinson's Disease Tremor: A Natural History Study

NCT02028858

TERMINATED Phase 1

Complementary and Alternative Medicine Sauna Detoxification Study: Phase I

NCT01905098

COMPLETED Phase 2

Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.

NCT01839344

COMPLETED

Haptoglobin and Iron in Parkinson's Disease

NCT02422992

COMPLETED

Evaluation of Coagulation in Multiple Sclerosis

NCT01711255

COMPLETED Phase 1

Intranasal Glutathione in Parkinson's Disease

NCT01398748

COMPLETED Phase 1

Sauna Detoxification Study: Pilot Feasibility

NCT01576822

COMPLETED

Integrative Oncology Outcomes Study in Breast Cancer

NCT01366248

COMPLETED NA

Comparative Effectiveness of Vitamin D and Repletion Strategies

NCT01524874

COMPLETED Early Phase 1

Feeding the Rainbow to Investigate Endothelial Dysfunction

NCT01175577

COMPLETED NA

Effects of Qigong, Tai Chi and Yoga Practice in Older Adults

NCT00710853

COMPLETED NA

Effects of Qigong on Type 2 Diabetic Patients

NCT00885846

TERMINATED Phase 1

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

NCT00332085

COMPLETED NA

In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television Technology

NCT00277277

What is open in the Bastyr University pipeline

2 recruiting of 19 indexed (11% open); 15 completed (79%).

Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Parkinson's Disease (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Bastyr University: open-pipeline peers nationwide

Peers matched on 19 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Bastyr University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 152025303540 0%5%10%15% Total trials Recruiting share Bastyr UniversityAlmirall, S.A.Church & Dwight CompanyCordis USDefense and Veterans Center for Integrative Pain ManagementCorewell Health WestEthiconRowan UniversitySaint John's Cancer Institute
Bastyr University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Bastyr University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 19 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Bastyr University page

19 registered trials is a research-attention snapshot, not an endorsement of Bastyr University or any single study.

  • 2 of Bastyr University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Parkinson's Disease is the condition Bastyr University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson's Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Bastyr University pipeline card: 19 registered trials from official public datasets.Report a data error.